Evidence map›Paper›PMID 42500392›Full record

ArticleFrontiers in neurology

Machine and deep learning based on magnetic resonance imaging to segment glioblastoma and predict the spread of recurrence: a multicenter retrospective protocol.

Luana Conte, Erica Lo Turco, Rosaria V Abbritti, Caterina Accettura, Giuseppe Raso, Edvige Iaboni, Ugo De Giorgi, Giorgio De Nunzio, Donato Cascio, Maria Caffo

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luana Conte *Department of Physics and Chemistry "E. Segrè", University of Palermo, Palermo, Italy.
Erica Lo Turco *Azienda Ospedaliero Universitaria "R. Dulbecco", Catanzaro, Italy.
Rosaria V AbbrittiService de Neurochirurgie Hôpital "Lariboisière", Paris, France.
Caterina AccetturaDepartment of Experimental Medicine, University of Salento, Lecce, Italy.
Giuseppe RasoDepartment of Physics and Chemistry "E. Segrè", University of Palermo, Palermo, Italy.
Edvige IaboniUnit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Ugo De GiorgiDepartment of Experimental Medicine, University of Salento, Lecce, Italy.
Giorgio De NunzioDepartment of Mathematics and Physics "E. De Giorgi", University of Salento, Lecce, Italy.
Donato CascioDepartment of Physics and Chemistry "E. Segrè", University of Palermo, Palermo, Italy.
Maria CaffoUnit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GB) remains one of the most aggressive brain tumors, with limited survival and high recurrence rates. In most cases, GB recurrence occurs locally, either on the residual tumor after surgery or within 2 cm of the resection cavity-but in rarer cases, tumor cells can spread beyond this margin, leading to distant recurrence. By Methods and analytics: A multicenter retrospective collection of clinical and radiological variables will be performed for all eligible GB patients. Variables will include demographic, surgical, pathological, and preoperative MRI features. Predictive modelling will use classical ML algorithms (e.g., Random Forest, SVM, Multilayer perceptron, etc.) and a 3D U-Net architecture for DL-based image segmentation. Dimensionality reduction (PCA, LASSO, etc.) will be used to prevent overfitting and improve model generalizability. Model performance will be assessed through Area Under the Curve (AUC), P-R curve, F-score, accuracy, sensitivity, specificity, confusion matrix, and Dice score for segmentation. Discussion: The development of Artificial Intelligence (AI)-based predictive models for GB is expected to provide a major contribution to outcome prediction, early targeted interventions, and personalized care. These tools may support optimized resource allocation, reduce healthcare costs, and improve patient and family outcomes. The findings from this study will serve as a foundation for a future prospective multicenter validation study.

Indexed as

deep learningglioblastomamachine learningradiomicsrecurrence

Identifiers

PMID42500392
PMCPMC13395678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.